CYP2D6 Genotype–Guided Tamoxifen Dosing in Hormone Receptor–Positive Metastatic Breast Cancer (TARGET-1): A Randomized, Open-Label, Phase II Study.

Autor: Tamura, Kenji, Imamura, Chiyo K., Takano, Toshimi, Saji, Shigehira, Yamanaka, Takeharu, Yonemori, Kan, Takahashi, Masato, Tsurutani, Junji, Nishimura, Reiki, Sato, Kazuhiko, Kitani, Akira, Ueno, Naoto T., Mushiroda, Taisei, Kubo, Michiaki, Fujiwara, Yasuhiro, Tanigawara, Yusuke
Zdroj: Journal of Clinical Oncology; 2/20/2020, Vol. 38 Issue 6, p558-566, 13p
Databáze: Supplemental Index